VCBeat Health Contact Us
Home Hansoh Pharmaceutical (03692) Grants 8.561 Million Restricted Share Units

Hansoh Pharmaceutical (03692) Grants 8.561 Million Restricted Share Units

Apr 28, 2025 21:19 CST Updated 21:19
Hansoh Pharma

Pharmaceutical Research, Production, and Sales

Hansoh Pharma (03692) announced that on April 28, 2025, a total of restricted share units representing 8,561,000 shares were granted to 776 grantees under the post-IPO Restricted Share Unit Scheme adopted by the company on May 27, 2019, subject to the acceptance of the grantees.